U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Malata African & Caribbean Market - 485911 - 03/03/2020
  1. Warning Letters

CLOSEOUT LETTER

Malata African & Caribbean Market MARCS-CMS 485911 —

Product:
Food & Beverages

Recipient:
Recipient Name
Edward Siaw, Dilys Wireko
Recipient Title
Co-Owners
Malata African & Caribbean Market

185 McClellan Street
Bronx, NY 10456
United States

Issuing Office:
Division of Northeast Imports-Compliance Branch

United States


Dear Mr. Siaw and Ms. Wireko,

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter NYK-2016-17, dated December 30, 2015. Based on our evaluation it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Slater Bartlett
Compliance Officer
Division of Northeast Imports-Compliance Branch
U.S. Food and Drug Administration

Back to Top